Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cyclacel Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 May 2016 Reuters Investment Profile 12 $20.00

CYCC: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

24 May 2016 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for CYCC

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

22 May 2016 ValuEngine, Inc. 11 $25.00

Cyclacel Pharmaceuticals

21 May 2016 S&P Capital IQ Quantitative Report 8 $92.00

CYCLACEL PHARMACEUTICALS INC (CYCC=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 May 2016 Pechala's Reports 2 $25.00

CYCLACEL PHARMACEUTICALS INC PFD (CYCCP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 May 2016 Pechala's Reports 2 $25.00

Value Graph: CYCLACEL PHARMAC -- CYCC

20 May 2016 Ford Investor Services, Inc. 1 $12.00

Cyclacel Pharmaceuticals, Inc. (CYCC) - Financial Analysis Review

Cyclacel Pharmaceuticals, Inc. (CYCC) - Financial Analysis Review Summary Cyclacel Pharmaceuticals, Inc. (Cyclacel Pharmaceut...

18 May 2016 GlobalData 54 $300.00

Wright Investors Service Comprehensive Report for Cyclacel Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 May 2016 Wright Reports 56 $75.00

Cyclacel Pharmaceuticals Inc: Downgraded to Above Average

02 May 2016 Sadif Analytics Prime 3 $10.00